Skip to content

Prosthetic Complications in Full-arch Screw-retained Implant Restorations Using Monolithic Zirconia Versus Titanium Frameworks: A Randomized Clinical Trial

Prosthetic Complications in Full-arch Screw-retained Implant Restorations Using Monolithic Zirconia Versus Titanium Frameworks: A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07657364
Enrollment
12
Registered
2026-06-18
Start date
2026-04-12
Completion date
2027-05-01
Last updated
2026-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complete Edentulism

Brief summary

The goal of this clinical trial is to to compare the prosthetic complication rate and Oral Health-Related Quality of Life (OHRQoL) between screw-retained monolithic zirconia frameworks and CNC-milled titanium frameworks with zirconia superstructures in completely edentulous patients restored with full-arch implant-supported prostheses over a follow-up period of 12 months.

Interventions

Intervention: Screw-Retained Monolithic Zirconia Prosthesis * Components: The prosthesis is a one-piece, full-arch framework milled from a single, monolithic zirconia blank. It includes the infrastructure, prosthetic teeth, and gingival contours. The prosthesis is screw-retained directly to multi-unit abutments. The prosthesis is delivered on the day of final insertion and is intended to be a definitive, long-term restoration. * Procedure for Tailoring: The prosthesis is fully customized for each participant using a digital workflow: 1. Digital Impression: An intraoral scan (Medit i700 scanner ) of the multi-unit abutment scan bodies will be performed. 2. Prosthesis Design: The prosthesis will be digitally designed in the CAD software BlenderforDental . 3. Fabrication: The design file will be processed in Millbox CAM software and milled from a zirconia blank using a 5-axis milling machine.

OTHERCNC-milled titanium framework and zirconia superstructure

The prosthesis consists of two parts: A CNC-milled titanium framework, and a CNC-milled zirconia superstructure that is cemented onto the framework. The titanium framework is screw-retained directly to multi-unit abutments. The zirconia superstructure is permanently cemented to the framework with resin cement.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

Single-blind (Statistician)

Intervention model description

This study is a two-arm, parallel-group, randomized controlled superiority trial with a 1:1 allocation ratio.

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Aged 18 years or older. 2. Able to understand the study procedures and provide written informed consent. 3. In good general health, classified as American Society of Anesthesiologists (ASA) Physical Status Class I or II. 4. Completely edentulous in the arch to be treated (maxilla and/or mandible). 5. A candidate for a full-arch, screw-retained implant-supported prosthesis, requiring 4 to 6 implants in the treatment arch. 6. Sufficient bone volume at planned implant sites to place implants of at least 3.5mm in diameter and 8mm in length. 7. Adequate crown height space (15-22 mm) for a fixed prosthesis. 8. A zone of keratinized mucosa at the crest of the ridge measuring at least 2 mm in width. 9. Opposing arch is fixed full-arch implant-supported prosthesis. 10. Demonstrates acceptable oral hygiene and the motivation to maintain it.

Exclusion criteria

1. Medical contraindications: * Uncontrolled diabetes (HbA1c \> 7.0%). * History of radiotherapy in the head and neck region. * History of intravenous bisphosphonate therapy. * Immunosuppressed or immunocompromised status. * Any other uncontrolled systemic disease that constitutes a contraindication for oral surgery. 2. Behavioral Factors: * Heavy smoking, defined as consumption of more than 10 cigarettes per day. * Presence of parafunctional habits (e.g., bruxism, clenching) as diagnosed by clinical examination. 3. Local Oral Factors: * Active, untreated periodontal disease in any remaining dentition. * Presence of acute oral infection or pathology at the intended surgical site. * Crown height space less than 15 mm or more than 22 mm. * Insufficient keratinized mucosa (\< 2 mm width) that cannot be corrected with a simple surgical procedure prior to implant placement. 4. General: * Pregnancy or lactation. * Participation in another interventional clinical trial. * Perceived inability to comply with the study protocol and follow-up schedule.

Design outcomes

Primary

MeasureTime frameDescription
Prosthetic complications1 yearThe primary outcome of this study is the incidence of prosthetic complications over 12-month follow-up period. A prosthetic complication is defined as any mechanical or technical issue affecting the prosthesis that requires clinical intervention. This will be assessed through a standardized clinical examination conducted by a calibrated examiner. The outcome for each participant will be recorded as a binary variable (Yes/No).

Secondary

MeasureTime frameDescription
Oral Health-Related Quality of Life (OHRQoL)1 yearThe secondary outcome of this study is the change in Oral Health-Related Quality of Life (OHRQoL) over the 12-month follow-up period. This will be measured using the validated Arabic version of the 5-item Oral Health Impact Profile (OHIP5-Ar) questionnaire (Alhajj et al., 2019). The questionnaire consists of 5 questions, each rated on a Likert scale (e.g., 0 = Never, 1 = Hardly ever, 2 = Occasionally, 3 = Fairly often, 4 = Very often). The total score ranges from 0 to 20, with a higher score indicating a greater negative impact on OHRQoL. The change from baseline to 3, 6 and 12 months will be analyzed.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 19, 2026